William Blair analyst Andrew Nicholas has maintained their neutral stance on NSP stock, giving a Hold rating on October 23.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Andrew Nicholas has given his Hold rating due to a combination of factors impacting Insperity’s financial performance. The company’s third-quarter results were notably below expectations, with gross profit significantly underperforming due to higher-than-anticipated benefit costs. This shortfall in gross profit, coupled with tight expense control measures that failed to offset the losses, resulted in an adjusted loss per share that was substantially lower than initial estimates.
Furthermore, healthcare costs have been trending above management’s projections, driven by increased pharmacy expenses and higher utilization rates. These cost pressures are expected to persist, influencing the company’s financial outlook negatively. Despite management’s efforts to address these challenges through strategic pricing and contract renegotiations, the anticipated recovery in earnings is not expected until 2026. Given these uncertainties and the potential for increased client attrition, Nicholas has opted for a Hold rating, reflecting a cautious stance on the stock’s near-term prospects.
In another report released on October 23, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $48.00 price target.
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NSP in relation to earlier this year.

